In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aradigm Corp.

www.aradigm.com

Latest From Aradigm Corp.

Breathing Life Into Inhaled Antibiotics: US FDA Tries To Move Class Ahead After Two Rejections

Workshop on inhaled antibiotics serves as unusual post mortem after two public rejections at advisory committee level; agency clearly eager not to see development in field end.  
Infectious Diseases Drug Approval Standards

Keeping Track: A Little Bit Of (Nearly) Everything

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Regulation

Corbus Takes On New Cystic Fibrosis Endpoint With Lenabasum

The US FDA has agreed to Corbus' plan to use pulmonary exacerbations as the only primary endpoint in a new large Phase II study, which is powered to serve as a registrational study.

Rare Diseases Clinical Trials

Aradigm's Linhaliq Suffers 'No' For Reducing Time To Exacerbations At US FDA Panel

Discordant results on Phase III primary endpoint in non-cystic fibrosis bronchiectasis patients troubled advisory committee members, although some suggested they would be more open to approval based upon secondary endpoint data on reduction in exacerbation frequency.

Advisory Committees Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Neurology, Nervous System
  • Poison (Antidote)
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aradigm Corp.
  • Senior Management
  • Igor Gonda, PhD, Pres. & CEO
    Nancy Pecota, CFO
    Juergen Froehlich, MD, CMO
  • Contact Info
  • Aradigm Corp.
    Phone: (510) 265-9000
    3929 Point Eden Way
    Hayward, CA 94545
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register